Skip to main content

10-10-2017 | Type 2 diabetes | Review | Article

SGLT2 inhibitors: Hypotheses on the mechanism of cardiovascular protection

Bell RM, Yellon DM. Lancet Diabetes Endocrinol 2018; 6: 435–437. doi: 10.1016/S2213-8587(17)30314-5

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics